Growth Hormone Axis · Growth Hormone Axis peptide (research)
Hexarelin
- Drug class
- Growth Hormone Axis peptide (research)
- Status
- Compounded (503A)
- Also known as
- hex, hexa, ghrp hexarelin, examorelin
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Hexarelin is studied for
- Strong GH release (research)
- Cardiac research (research)
- Recovery (research)
Mechanism of action
Hexarelin is being studied in the growth hormone axis category. Potent GH secretagogue studied for cardiac and growth hormone axis support. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Hexarelin?
Hexarelin is a growth hormone axis peptide. Potent GH secretagogue studied for cardiac and growth hormone axis support.
What is Hexarelin studied for?
Published research has examined Hexarelin for strong gh release, cardiac research, recovery. Human clinical evidence varies by indication.
Is Hexarelin FDA-approved?
No. Hexarelin is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Hexarelin used in research?
Protocols vary by study. Hexarelin is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Hexarelin is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.